Spyre Therapeutics, Inc. SYRE
- SPY001 — Ulcerative Colitis Phase 2
- SPY001 — Crohn's Disease Phase 2
- SPY120 — Ulcerative Colitis Phase 2
- SPY130 — Ulcerative Colitis Phase 2
α4β7 (1 companies · 4 programs)
Companies with an active program directed at α4β7.